Pulmonary Hypertension Archives - The Cardiology Advisor

RV Dysfunction Index Predicts Outcomes in Patients With HFrEF, PH Postdischarge

By

January 14, 2022

Researchers examined the effects of RV dysfunction on the clinical outcomes of patients hospitalized with heart failure with and without pulmonary hypertension.

Hypertension

Low Forced Expiratory Volume in Chronic Thromboembolic Pulmonary Hypertension

By

Bryant Moeller

January 12, 2022

Is there a significant relationship between obstructive impairment and the low forced expiratory volumes frequently seen in patients with CTEPH?

Hypertension

Linking Severity, Prognosis of Chronic Thromboembolic PH With HRR1 Post Exercise

By

Sheila Jacobs

December 28, 2021

Is there a link between the severity and prognosis of chronic thromboembolic pulmonary hypertension and attenuated heart rate recovery at 1 minute?

Obstructive Sleep Apnea, tablet, stethoscope

Hypertension

Risk Factors for Pulmonary Hypertension Combined With Obstructive Sleep Apnea

By

Virginia A. Schad, PharmD, RPh

December 17, 2021

A recent Chinese study sought to identify clinical predictors of pulmonary hypertension combined with obstructive sleep apnea.

Pulmonary Vasculature

Inhaled Treprostinil Approval Decision Delayed Over Inspection Issue

By

Diana Ernst, RPh

October 21, 2021

Tyvaso DPI is an investigational drug-device combination therapy that consists of a dry powder formulation of treprostinil and a small, portable, dry powder inhaler.

Pulmonary Vasculature

Initial Triple vs Dual Oral Combination Therapy for Newly Diagnosed PAH

By

Jessica Nye, PhD

October 5, 2021

A study investigated the efficacy of double or triple pharmacotherapy in pulmonary arterial hypertension.

News

Presence of Pleural vs Pericardial Effusion in Pulmonary Hypertension

By

Sheila Jacobs

September 13, 2021

Researchers examined the link between pulmonary hemodynamic variables and the presence of pericardial and pleural effusion.

Pulmonary Vasculature

Pre Capillary Pulmonary Hypertension: Patient Characteristics and Prognosis

By

Bryant Moeller

September 3, 2021

Is the 2018 World Symposium on Pulmonary Hypertension definition of pre-capillary pulmonary hypertension beneficial in clinical practice?

Pulmonary Vasculature

Longitudinal Value of Questionnaires for Health-Related QoL in PAH

By

Brandon May

August 30, 2021

Health-related quality of life questionnaires created for pulmonary hypertension may be useful for clinicians in daily practice.

Pulmonary Vasculature

Inhaled Imatinib Designated an Orphan Drug for PAH

By

Brian Park, PharmD

August 30, 2021

AER-901 is an investigational drug-device combination therapy that consists of a nebulized formulation of imatinib and the Fox device, a breath-actuated smart nebulizer.